Tropic Biosciences is a Biotech company. It has raised $105M in total funding. Backed by Forbion, Corteva, Just Climate.
Tropic Biosciences funding overview
Tropic Biosciences is a Biotech company. Tropic Biosciences has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include Forbion, Corteva, Just Climate, IQ Capital, ABN Amro, Invest International and 11 others. 17 distinct backers are named across the disclosed rounds.
Tropic Biosciences at a glance
Total raised
$105M
Industry
Biotech
Notable investors
Forbion, Corteva, Just Climate, IQ Capital, ABN Amro, Invest International, Temasek, Five Seasons Ventures
Frequently asked about Tropic Biosciences funding
How much has Tropic Biosciences raised?
Tropic Biosciences has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Tropic Biosciences?
Forbion, Corteva, Just Climate, IQ Capital, ABN Amro, Invest International are named among the investors backing Tropic Biosciences.
What was the latest Tropic Biosciences funding round?
No round stage has been disclosed for Tropic Biosciences.
Where is Tropic Biosciences based?
No headquarters location is disclosed for Tropic Biosciences.
What sector does Tropic Biosciences operate in?
Tropic Biosciences is tracked under Biotech, with $105M in disclosed funding.
Round data for Tropic Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies and backer lists below.
